
Michael Tomblyn MD MS
Breast Cancer, Hematologic Malignancies, Urologic Cancer
Physician
Join to View Full Profile
55 Humphreys Center DriveSuite 100Memphis, TN 38120
Phone+1 901-226-0340
Dr. Tomblyn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MinnesotaResidency, Radiation Oncology, 2005 - 2009
University of MinnesotaInternship, Internal Medicine, 2004 - 2005
Rush Medical College of Rush University Medical CenterClass of 2004
Certifications & Licensure
AR State Medical License 2024 - 2027
TN State Medical License 2021 - 2027
MS State Medical License 2024 - 2026
IL State Medical License 2016 - 2023
FL State Medical License 2009 - 2019
KS State Medical License 2016 - 2018
MN State Medical License 2007 - 2009
American Board of Radiology Radiation Oncology
Clinical Trials
- Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL Start of enrollment: 2010 May 01
Publications & Presentations
PubMed
- 6 citationsACR-ACNM-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radium-223.Mark D. Hurwitz, John R. Buscombe, Heather A. Jacene, Alan K. Klitzke, Dominick Lamonica
American Journal of Clinical Oncology. 2020-08-01 - 11 citationsRandomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: re...Michael J. Seider, Stephanie L. Pugh, Corey J. Langer, Gwen Wyatt, W. Demas
Annals of Nuclear Medicine. 2018-08-09 - 19 citationsAnti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphomaThomas E. Witzig, Michael B Tomblyn, Jamal Misleh, Ebenezer A. Kio, Robert M. Sharkey
Haematologica. 2014-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









